Saxenda weight loss pen: separating TikTok hype from clinical data

What did @achibrabra actually say?

Honestly? Not much that can be fact-checked. The transcript captured in this video appears to be song lyrics, not medical commentary. The words attributed to @achibrabra are lines like "we ain't just up in the clouds" and "I just saw your light" — which are clearly audio from a background track, not the creator speaking directly about Saxenda or weight loss.

What we do have is the caption, which is where the real claims live. Translated from Thai, it reads roughly: "Love yourself, not painful at all even one day but costs money" — paired with the disclosure that she is "under doctor supervision and adjusting eating behavior alongside" the injections. The hashtags confirm this is about Saxenda (liraglutide), a GLP-1 receptor agonist.

So we're fact-checking a caption and a product experience, not a spoken medical claim. That context matters.

Does the science back this up?

The core implication — that Saxenda can support weight loss without pain when used under medical supervision alongside dietary changes — is broadly supported by the evidence. But "no pain" is where things get complicated.

Liraglutide 3.0 mg (Saxenda) was studied in the SCALE Obesity and Prediabetes trial (Pi-Sunyer et al., 2015, New England Journal of Medicine), which found participants lost an average of 8.4 kg over 56 weeks versus 2.8 kg on placebo. That's real, meaningful weight loss. The catch: 63.6% of participants reported nausea, and gastrointestinal side effects were the primary reason for discontinuation in about 9.9% of cases.

The "no pain" experience the creator describes is plausible for some people, especially if injection technique is good and doses are titrated slowly. But it is not the majority experience in clinical trials. Nausea, vomiting, and injection site reactions are common, not rare. The creator's experience is valid as personal testimony — it just shouldn't be read as typical.

What did they get wrong (or right)?

Credit where it's due: the caption disclosure is better than most GLP-1 content on TikTok. Saying she is "under doctor supervision" and "adjusting eating behavior alongside" the injection is exactly what responsible use of liraglutide looks like. Saxenda is not a standalone fix. A 2021 study by Rubino et al. in JAMA showed that patients who stopped semaglutide (a related GLP-1 drug) regained two-thirds of their lost weight within a year — reinforcing that behavioral change isn't optional, it's load-bearing.

What's missing, and what's problematic in its absence, is any acknowledgment of who Saxenda is approved for. The FDA indication is adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition. The framing of "love yourself, not painful" could read as an invitation for anyone to try it, which is not accurate or safe guidance.

• Right: Doctor supervision disclosed
• Right: Behavioral eating changes mentioned as part of the process
• Missing: Side effect acknowledgment
• Missing: Eligibility criteria for appropriate use

What should you actually know?

Saxenda is a legitimate, FDA-approved medication for weight management. Liraglutide 3.0 mg is not a shortcut — it's a daily subcutaneous injection that works best when paired with caloric adjustment and physical activity, which the creator at least gestures toward.

The "no pain" framing deserves scrutiny. In the SCALE trial, nausea affected the majority of users. Some people do tolerate it well, particularly with slow dose escalation starting at 0.6 mg and increasing weekly. But tolerance varies substantially, and one person's painless experience doesn't generalize.

Cost is real, and the creator acknowledges it. Saxenda runs roughly $1,300-$1,400 per month out of pocket in the US without insurance coverage, which is a genuine barrier. Generic liraglutide is not currently available in the US market as of 2024.

If you're considering Saxenda or any GLP-1 medication for weight management, the starting point is a conversation with a licensed clinician who can assess your medical history, current medications, and whether the risk-benefit calculation makes sense for you specifically. Thyroid C-cell tumor risk — including a black box warning for medullary thyroid carcinoma — is a contraindication that a TikTok caption cannot screen for.